121 related articles for article (PubMed ID: 23771060)
1. N6-benzyladenosine derivatives as novel N-donor ligands of platinum(II) dichlorido complexes.
Starha P; Popa I; Trávníček Z; Vančo J
Molecules; 2013 Jun; 18(6):6990-7003. PubMed ID: 23771060
[TBL] [Abstract][Full Text] [Related]
2. Platinum(II) oxalato complexes involving adenosine-based N-donor ligands: synthesis, characterization and cytotoxicity evaluation.
Starha P; Popa I; Trávníček Z
Molecules; 2014 Mar; 19(3):3832-47. PubMed ID: 24662093
[TBL] [Abstract][Full Text] [Related]
3. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
[TBL] [Abstract][Full Text] [Related]
4. Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: preparation, characterization and in vitro cytotoxicity.
Trávnícek Z; Starha P; Popa I; Vrzal R; Dvorák Z
Eur J Med Chem; 2010 Oct; 45(10):4609-14. PubMed ID: 20692737
[TBL] [Abstract][Full Text] [Related]
5. Novel iron complexes bearing N6-substituted adenosine derivatives: synthesis, magnetic, 57Fe Mössbauer, DFT, and in vitro cytotoxicity studies.
Trávnícek Z; Mikulík J; Cajan M; Zboril R; Popa I
Bioorg Med Chem; 2008 Sep; 16(18):8719-28. PubMed ID: 18723360
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2009 Jul; 103(7):978-88. PubMed ID: 19457557
[TBL] [Abstract][Full Text] [Related]
7. Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].
Trávnícek Z; Malon M; Zatloukal M; Dolezal K; Strnad M; Marek J
J Inorg Biochem; 2003 Apr; 94(4):307-16. PubMed ID: 12667701
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
[TBL] [Abstract][Full Text] [Related]
9. Diverse in vitro and in vivo anti-inflammatory effects of trichlorido-gold(III) complexes with N6-benzyladenine derivatives.
Křikavová R; Hošek J; Suchý P; Vančo J; Trávníček Z
J Inorg Biochem; 2014 May; 134():92-9. PubMed ID: 24584156
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of in vitro cytotoxicity of 6-benzylaminopurine carboplatin derivatives against human cancer cell lines and primary human hepatocytes.
Dvořák Z; Starha P; Trávníček Z
Toxicol In Vitro; 2011 Apr; 25(3):652-6. PubMed ID: 21232594
[TBL] [Abstract][Full Text] [Related]
11. Mixed natural arylolefin-quinoline platinum(II) complexes: synthesis, structural characterization and in vitro cytotoxicity studies.
Chi NTT; Thong PV; Mai TTC; Van Meervelt L
Acta Crystallogr C Struct Chem; 2018 Dec; 74(Pt 12):1732-1743. PubMed ID: 30516159
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
13. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, spectral study and cytotoxicity of platinum(II) complexes with 2,9-disubstituted-6-benzylaminopurines.
Malon M; Trávnícek Z; Marek R; Strnad M
J Inorg Biochem; 2005 Nov; 99(11):2127-38. PubMed ID: 16143400
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
Vrzal R; Starha P; Dvorák Z; Trávnícek Z
J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
[TBL] [Abstract][Full Text] [Related]
16. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and in vitro antitumor activity of platinum(II) oxalato complexes involving 7-azaindole derivatives as coligands.
Štarha P; Trávníček Z; Popa I; Dvořák Z
Molecules; 2014 Jul; 19(8):10832-44. PubMed ID: 25068781
[TBL] [Abstract][Full Text] [Related]
18. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
Wagner G; Marchant A; Sayer J
Dalton Trans; 2010 Sep; 39(33):7747-59. PubMed ID: 20657943
[TBL] [Abstract][Full Text] [Related]
20. Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity.
Trávnícek Z; Krystof V; Sipl M
J Inorg Biochem; 2006 Feb; 100(2):214-25. PubMed ID: 16386795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
